196 related articles for article (PubMed ID: 8657828)
21. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group.
Studd J; Pornel B; Marton I; Bringer J; Varin C; Tsouderos Y; Christiansen C
Lancet; 1999 May; 353(9164):1574-8. PubMed ID: 10334256
[TBL] [Abstract][Full Text] [Related]
22. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.
Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J
Maturitas; 1996 Nov; 25(3):161-73. PubMed ID: 8981333
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous 17 beta-estradiol replacement therapy in hypertensive postmenopausal women.
Osório-Wender MC; Vitola D; Spritzer PM
Braz J Med Biol Res; 1997 Sep; 30(9):1047-53. PubMed ID: 9458963
[TBL] [Abstract][Full Text] [Related]
25. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia.
Saletu B; Grünberger J; Anderer P; Linzmayer L
Methods Find Exp Clin Pharmacol; 1996; 18(1):67-81. PubMed ID: 8721258
[TBL] [Abstract][Full Text] [Related]
26. A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women.
Haines CJ; Yim SF; Chung TK; Lam CW; Lau EW; Ng MH; Chin R; Lee DT
Maturitas; 2003 Mar; 44(3):207-14. PubMed ID: 12648884
[TBL] [Abstract][Full Text] [Related]
27. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
Saletu B; Anderer P; Linzmayer L; Semlitsch HV; Lindeck-Pozza E; Assandri A; di Padova C; Saletu-Zyhlarz GM
J Neural Transm (Vienna); 2002 Dec; 109(12):1505-26. PubMed ID: 12486491
[TBL] [Abstract][Full Text] [Related]
29. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
30. Acute effect of oestrogen replacement therapy on treadmill performance in postmenopausal women with coronary artery disease.
Holdright DR; Sullivan AK; Wright CA; Sparrow JL; Cunningham D; Fox KM
Eur Heart J; 1995 Nov; 16(11):1566-70. PubMed ID: 8881849
[TBL] [Abstract][Full Text] [Related]
31. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
[TBL] [Abstract][Full Text] [Related]
32. A comparative multicenter study of two transdermal estradiol replacement therapies in the treatment of postmenopausal symptoms.
Van Leusden HA; Albertyn G; Verlaine C; Van Ruymbeke J
Int J Fertil Menopausal Stud; 1993; 38(4):210-8. PubMed ID: 8401679
[TBL] [Abstract][Full Text] [Related]
33. Improvement in depression with oestrogen treatment in women with schizophrenia.
Lascurain MB; Camuñas-Palacín A; Thomas N; Breadon C; Gavrilidis E; Hudaib AR; Gurvich C; Kulkarni J
Arch Womens Ment Health; 2020 Apr; 23(2):149-154. PubMed ID: 30903287
[TBL] [Abstract][Full Text] [Related]
34. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
Bachmann GA; Schaefers M; Uddin A; Utian WH
Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
[TBL] [Abstract][Full Text] [Related]
35. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
[TBL] [Abstract][Full Text] [Related]
37. Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).
Saletu B; Anderer P; Saletu-Zyhlarz GM; Gruber D; Metka M; Huber J
Psychopharmacology (Berl); 2005 Apr; 178(4):389-99. PubMed ID: 15765254
[TBL] [Abstract][Full Text] [Related]
38. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
[TBL] [Abstract][Full Text] [Related]
39. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
[TBL] [Abstract][Full Text] [Related]
40. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial.
Jackson S; Shepherd A; Brookes S; Abrams P
Br J Obstet Gynaecol; 1999 Jul; 106(7):711-8. PubMed ID: 10428529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
